SeaStar Medical Holding Corporation Share Price
ICUSeaStar Medical Holding Corporation Stock Performance
Open $4.05 | Prev. Close $3.92 | Circuit Range N/A |
Day Range $3.98 - $4.21 | Year Range $0.22 - $5.04 | Volume 1,856 |
Average Traded $4.06 |
SeaStar Medical Holding Corporation Share Price Chart
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
SeaStar Medical Holding Corporation Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-May-26 | $3.85 | $3.95 | +0.38% |
19-May-26 | $3.92 | $3.94 | -1.38% |
18-May-26 | $3.89 | $3.99 | +0.25% |
15-May-26 | $4.13 | $3.98 | -11.95% |
14-May-26 | $4.48 | $4.52 | -2.16% |
13-May-26 | $4.79 | $4.62 | -4.64% |
12-May-26 | $4.74 | $4.84 | +8.39% |